A full list of publications can be found on Pubmed.
Select publications from my research and collaborations include:
Clinical Informatics and Data Science:
Fohner AE, Greene JD, Lawson BL, Chen JH, Kipnis P, Escobar GJ, Liu VX. Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning. J Am Med Inform Assoc. 2019 Jul 17;. doi: 10.1093/jamia/ocz106. [Epub ahead of print] PubMed PMID: 31314892.
Risk Prediction in Heart Failure: New Methods, Old Problems. JACC Heart Fail. 2020 Jan;8(1):22-24. doi: 10.1016/j.jchf.2019.08.015. Epub 2019 Oct 9. PubMed PMID: 31606359.
Identifying risk of adverse outcomes in COVID-19 patients via artificial intelligence-powered analysis of 12-lead intake electrocardiogram. Cardiovasc Digit Health J. 2022 Apr;3(2):62-74. doi: 10.1016/j.cvdhj.2021.12.003. Epub 2021 Dec 31. PubMed PMID: 35005676; PubMed Central PMCID: PMC8719367.
Pharmacogenetics/Precision Medicine:
Fohner AE, Ranatunga DK, Thai KK, Lawson BL, Risch N, Oni-Orisan A, Jelalian AT, Rettie AE, Liu VX, Schaefer CA. Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. Pharmacogenet Genomics. 2019 Oct;29(8):192-199. doi: 10.1097/FPC.0000000000000383. PubMed PMID: 31461080.
Fohner AE, Robinson R, Yracheta J, Dillard DA, Schilling B, Khan B, Hopkins S, Boyer BB, Black J, Wiener H, Tiwari HK, Gordon A, Nickerson D, Tsai JM, Farin FM, Thornton TA, Rettie AE, Tummel KE. “Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.” Pharmacogenet Genomics. 2015 Jul;25(7):343-53. PMID: 25946405
Public Health Policy/Practice Guidelines:
Fohner, A.E. N.A Garrison, M.A Austin, W Burke. “Carnitine Palmitoyltransferase 1A P479L and Infant Death: Policy Implications of Emerging Data.” Genetics in Medicine. In press.
Fohner AE, Wang Z, Yracheta J, O’Brien D, Hopkins SE, Black J, Philip J, Wiener HW, Tiwari HK, Stapleton PL, Tsai JM, Thornton TA, Boyer BB, Thummel KE. “Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup’ik Study Population from Southwestern Alaska.” J. Nutr. dos: 10.3945/jn115.223388.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Clin Pharmacol Ther. 2021 Feb;109(2):302-309. doi: 10.1002/cpt.2008. Epub 2020 Sep 6. Review. PubMed PMID: 32779747; PubMed Central PMCID: PMC7831382.
Research equity:
Fohner AE, Volk KG, Woodahl EL. Democratizing Precision Medicine Through Community Engagement. Clin Pharmacol Ther. 2019 Sep;106(3):488-490. doi: 10.1002/cpt.1508. Epub 2019 Jun 17. PubMed PMID: 31206610; PubMed Central PMCID: PMC6692197.
Dementia, Alzheimer’s Disease, Cognitive Decline:
Fohner AE, Bartz TM, Tracy RP, Adams HHH, Bis JC, Djousse L, Satizabal CL, Lopez OL, Seshadri S, Mukamal KJ, Kuller LH, Psaty BM, Longstreth WT Jr. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study. Neurology. 2022 Mar 1;98(9):e903-e911. doi: 10.1212/WNL.0000000000013229. Epub 2021 Dec 17. PubMed PMID: 34921102; PubMed Central PMCID: PMC8901174.